Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study
- 27 May 2015
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 75 (13) , 1384-1393
Abstract
BACKGROUND Epidemiologic studies suggest that statin use may be inversely associated with risk of prostate cancer, but prior studies have focused predominantly on non‐Hispanic white populations. METHODS We evaluated the association between statin use and prostate cancer risk in the Southern Community Cohort Study (SCCS). Study participants were 32,091 men aged 40–79 at baseline, 67% of whom were non‐Hispanic black. Between study enrollment (2002–2009) and December 31, 2010, 570 prostate cancer cases were diagnosed, including 324 low‐grade cancers (Gleason score 7 or Gleason pattern 4 + 3). Analyses of overall prostate cancer were conducted using Cox regression and analyses of grade‐specific cancer were conducted using competing risks models. RESULTS Ten percent of non‐Hispanic black men and 22% of non‐Hispanic white men reported use of statins at study enrollment. As compared to non‐use, statin use was associated with a non‐significant 14% lower risk of prostate cancer in multivariable models (Hazard Ratio [HR]:0.86; 95% Confidence Interval [CI]: 0.63–1.18). This association was stronger for high‐grade cancer (HR: 0.62; 95%CI: 0.30, 1.28) than low‐grade cancer (HR:0.98; 95%CI: 0.65–1.48). Results were similar by race/ethnicity (p‐interaction: 0.41) and did not vary by history of prostate‐specific antigen [PSA] screening (p‐interaction: 0.65). CONCLUSIONS Results suggest no strong association between statin use and prostate cancer risk overall, and further suggest that if a modest protective effect does exist, it does not vary by race/ethnicity and may be restricted to high‐grade tumors, although power to detect differences by subgroup was limited. Prostate 75:1384–1393, 2015.Keywords
Funding Information
- National Cancer Institute/National Institutes of Health (T32 CA009001)
This publication has 45 references indexed in Scilit:
- Minimal detection bias in the inverse association between statin drug use and advanced prostate cancer risk: A simulation studyCancer Epidemiology, 2011
- The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancerCancer Causes & Control, 2010
- The Association Between Statin Use and the Diagnosis of Prostate Cancer in a Population Based CohortJournal of Urology, 2010
- Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch databaseBMJ, 2010
- Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001–2004Cancer Causes & Control, 2010
- Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention TrialCancer Epidemiology, Biomarkers & Prevention, 2009
- Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohortCancer Causes & Control, 2009
- Statins in tumor suppressionCancer Letters, 2008
- Risk factors for prostate cancer incidence and progression in the health professionals follow‐up studyInternational Journal of Cancer, 2007
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999